TOXICOLOGY AND CARCINOGENICITY STUDIES OF DIURETICS IN F344 RATS AND B6C3F1 MICE .2. FUROSEMIDE

被引:19
作者
BUCHER, JR [1 ]
HUFF, J [1 ]
HASEMAN, JK [1 ]
EUSTIS, SL [1 ]
DAVIS, WE [1 ]
MEIERHENRY, EF [1 ]
机构
[1] SRI INT,MENLO PK,CA 94025
关键词
carcinogenicity; chronic toxicity; diuretic; furosemide; mice; nephrotoxin; rats;
D O I
10.1002/jat.2550100510
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Toxicology and carcinogenesis studies of furosemide, a widely used diuretic, were conducted by administering diets containing the drug to both sexes of F344 rats and B6C3F1 mice in 14‐day, 13‐week and 2‐year studies. Deaths occurred among rats and mice receiving diets containing 46 000 ppm furosemide in 14‐day studies, and animals given diets containing lower concentrations lost weight. No deaths were seen in 13‐week studies using top concentrations ranging from 10 000 to 20 000 ppm, but animals at higher concentrations had lower weight gains than controls. Nephrosis in rats and mice was the only significant compound‐related lesion observed in the prechronic studies. In 2‐year studies, rats received diets containing 0, 350 or 700 ppm furosemide and mice received diets containing 0, 700 or 1400 ppm furosemide. Survival of dosed and control rats of both sexes and male mice was similar; survival of high‐dose female mice was lower than controls. Nephropathy was increased in male rats and in male and female mice. In female mice, increased malignant tumors of the mammary gland were associated with furosemide administration. In male rats, marginal increases in tubular cell neoplasms of the kidney and in meningiomas of the brain were observed in dosed animals, but these were not considered to be related clearly to exposure to furosemide. Copyright © 1990 John Wiley & Sons, Ltd.
引用
收藏
页码:369 / 378
页数:10
相关论文
共 49 条
[1]  
[Anonymous], 1987, REGISTRY TOXIC EFFEC
[2]  
BEERMANN B, 1984, ACTA PHARMACOL TOX, V54, P17
[3]  
BIDIVILLE J, 1986, J PHARMACOL EXP THER, V237, P636
[4]  
BOORMAN GA, 1985, HDB CARCINOGEN TESTI, P345
[5]  
BOURLAND WA, 1977, J PHARMACOL EXP THER, V202, P221
[6]  
BRANCH RA, 1983, FED PROC, V42, P1699
[7]  
CHRISTENSEN S, 1986, J PHARMACOL EXP THER, V239, P211
[8]  
COX DR, 1972, J R STAT SOC B, V34, P187
[9]  
DYBING E, 1977, ACTA PHARMACOL TOX, V41, P89
[10]   CELLULAR MECHANISM OF ACTION OF LOOP DIURETICS - IMPLICATIONS FOR DRUG EFFECTIVENESS AND ADVERSE-EFFECTS [J].
FEIG, PU .
AMERICAN JOURNAL OF CARDIOLOGY, 1986, 57 (02) :A14-A19